Venus Remedies
VENUSREMNSE

Venus Remedies

₹894.45-33.05 (3.56%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
881.15
Today’s high
944.75
52 week low
277.95
52 week high
944.75
Open price
935.00
Previous close
927.50
Live volume
78,438
Lower circuit
849.75
Upper circuit
939.15

Fundamentals

Market Cap
₹1,195Cr
ROE
10.66%
P/E Ratio(TTM)
15.66
EPS(TTM)
57.09
P/B Ratio
2.01
Dividend Yield
0.00%
Industry P/E
32.86
Book Value
444.61
Debt to Equity
0.02
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Venus Remedies Limited is a research-driven Indian pharmaceutical company with a global presence, specializing in the injectables space. The company's core vision is to leave a positive footprint on human health by creating an institution that transcends the mortal being. A key part of its Mission 2026 is to foster innovative therapies that target the major health challenge of Antimicrobial Resistance. It develops solutions for human ailments in critical areas like oncology, neurology, pain management, and also has a herbal product portfolio. The company's priority regions are the Middle East, South-East Asia, Africa, and Latin America, where it aims to be a partner of choice. With over 1040 marketing authorisations and more than 25 GMP approvals, the company has expanded its boundaries to over 90 countries.;
MD/CEO
Pawan Chaudhary
Founded in
1989
NSE symbol
VENUSREM

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Retail And Others
54.96%
Promoters
41.76%
Foreign Institutions
2.26%
Other Domestic Institutions
1.03%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹3.39
0.00 (--)
L
    H
    10.11-0.130
    2026
    29
    Jan
    Quarterly Result
    Release date
    2025
    10
    Nov
    Quarterly Result
    Release date
    1
    Aug
    Quarterly Result
    Release date
    26
    May
    Annual Result
    Release date
    4
    Feb
    Quarterly Result
    Release date
    2024
    29
    Oct
    Quarterly Result
    Release date
    13
    Aug
    Quarterly Result
    Release date
    30
    May
    Result
    Release date
    Events calendar
    View upcoming events in other stocks